BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2182599)

  • 21. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
    Cabezudo E; Carrara P; Morilla R; Matutes E
    Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4, CD8 and NK subsets in B-CLL.
    Vuillier F; Tortevoye P; Binet JL; Dighiero G
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):331-4. PubMed ID: 3265505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
    Defrance T; Vanbervliet B; Durand I; Banchereau J
    Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD5-positive B-cells of the fetal and adult spleen lymphoid tissue: an immunophenotypical study.
    Valente G; Geuna M; Novero D; Arisio R; Palestro G; Stramignoni A
    Verh Dtsch Ges Pathol; 1990; 74():155-8. PubMed ID: 1708575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia.
    Musolino C; Alonci A; Allegra A; Di Cesare E; Orlando A; Grosso P; Buda G; Squadrito G
    Int J Hematol; 1992 Dec; 56(3):213-7. PubMed ID: 1477333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic lymphocytic leukemia coexisting with chronic myelomonocytic leukemia.
    Ferrara F; Del Vecchio L; Antonolfi I; Mele G; Rametta V; Cimino R
    Haematologica; 1992; 77(2):171-3. PubMed ID: 1398303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts.
    Fournier S; Tran ID; Suter U; Biron G; Delespesse G; Sarfati M
    Leuk Res; 1991; 15(7):609-18. PubMed ID: 1830631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heterogeneity of surface antigens in chronic B-cell lymphoid leukemia].
    Pálóczi K; Benczúr M; Mihalik R; Solti V; Hollán Z
    Orv Hetil; 1991 Jan; 132(1):7-8, 11-3. PubMed ID: 1987510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells.
    Vilpo J; Hulkkonen J; Hurme M; Vilpo L
    Leukemia; 2002 Sep; 16(9):1691-8. PubMed ID: 12200683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A further characterization of B-CLL lymphocytes: phenotypic and functional studies.
    Merle-Béral H
    Nouv Rev Fr Hematol (1978); 1990; 32(5):319-21. PubMed ID: 2099403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoregulatory T cells in B cell chronic lymphocytic leukaemia: evidence of a unique phenotype a flow cytometric study.
    Mackenzie RH; Sewell HF; Dawson AA; Ratcliffe MA; Bennett NB; King DJ
    Dis Markers; 1990; 8(3):137-43. PubMed ID: 1703059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dense lymphocytic infiltrates associated with non-melanoma skin cancer in patients with chronic lymphocytic leukemia.
    Wilson ML; Elston DM; Tyler WB; Marks VJ; Ferringer T
    Dermatol Online J; 2010 Mar; 16(3):4. PubMed ID: 20233561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia.
    Sarfati M; Fournier S; Christoffersen M; Biron G
    Leuk Res; 1990; 14(1):47-55. PubMed ID: 2137545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell activation-associated antigen expression by neoplastic T-cells.
    Chadburn A; Inghirami G; Knowles DM
    Hematol Pathol; 1992; 6(3):131-41. PubMed ID: 1429341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal cellular counterparts of B cell chronic lymphocytic leukemia.
    Freedman AS; Boyd AW; Bieber FR; Daley J; Rosen K; Horowitz JC; Levy DN; Nadler LM
    Blood; 1987 Aug; 70(2):418-27. PubMed ID: 3496927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biology of the neoplastic lymphocyte in B-CLL.
    Dighiero G
    Baillieres Clin Haematol; 1993 Dec; 6(4):807-20. PubMed ID: 8038491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders.
    Carbone A; Pinto A; Gloghini A; Volpe R; Zagonel V
    Hum Pathol; 1992 Apr; 23(4):438-48. PubMed ID: 1563746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis.
    Carlsson M; Matsson P; Rosén A; Sundström C; Tötterman TH; Nilsson K
    Leukemia; 1988 Nov; 2(11):734-44. PubMed ID: 3263557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical analysis of 10 patients with chronic lymphoid leukemia].
    Fukuda T; Makino S; Tamura K; Suzumiya J; Kimura N; Ohshima K; Kikuchi M; Sagawa K
    Rinsho Ketsueki; 1992 Aug; 33(8):1017-24. PubMed ID: 1404856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.